OcuMension, Immunotech Bio launch IPOs

Pharma_drugs_adobe_575x375.jpg
By Jonathan Breen
29 Jun 2020

OcuMension Therapeutics hit the market on Monday with its HK$1.55bn ($200m) IPO, the latest in a stream of healthcare sector listings on the city’s stock exchange.

The issuer has enlisted sponsors Goldman Sachs and Morgan Stanley and joint global co-ordinator UBS to market its IPO, which comes alongside a host of other live deals including a listing by biotechnology firm Immunotech Biopharm.

Up for grabs are 105.9m shares in OcuMension at HK$13.16 to HK$14.66 ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial